the chairman of the ways and means committee of the senate is concerned about the annual cost of surveillance and production of a new influenza vaccine every year. he reasons sensibly that while there are occasional improvements to other vaccines, it should not be necessary every year and he proposes to look at the situation in every third year, reasoning that annual laboratory progress would not be so great as to warrant annual change. you are designated to discuss it with him. outline the discussion